Nama Insights

iShares Biotechnology ETF (IBB)

Health · iShares · NASDAQ

HealthETF
iShares Biotechnology ETF (IBB) is an exchange-traded fund in the Health category. It has $11.20B in assets, an expense ratio of 0.44% and a 0.16% dividend yield. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Assets under management$11.20B
Expense ratio0.44%
CategoryHealth
Dividend yield0.16%
NAV$217.59
Fund familyiShares
ExchangeNASDAQ

Top holdings

The largest positions iShares Biotechnology ETF reports, by weight.

HoldingNameWeight
GILD Gilead Sciences Inc 8.08%
AMGN Amgen Inc 7.78%
VRTX Vertex Pharmaceuticals Inc 7.62%
REGN Regeneron Pharmaceuticals Inc 5.28%
MRNA Moderna Inc 4.94%
NTRA Natera Inc 3.91%
ARGX argenx SE ADR 3.74%
ILMN Illumina Inc 2.89%
RVMD Revolution Medicines Inc Ordinary Shares 2.78%
BIIB Biogen Inc 2.33%

Other Health ETFs

Explore live IBB data on Nama Insights →